The cell freezing media market plays a pivotal role in preserving stem cells, primary cells, and cell lines, enabling ...

The global cell cryopreservation market size was valued at US$ 14.9 Bn in 2024 and is projected to reach US$ 104.8 Bn by 2035 ...

Throughout the journey from manufacturing to patient delivery, low efficiency and poor biocompatibility of conventional preservatives are barriers to successful cell preservation. Our webinar will ...

Teplizumab has shown significant preservation of C-peptide levels in newly diagnosed type 1 diabetes (T1D) patients, indicating the potential for modifying disease progression. Combining teplizumab ...

As we proceed into the decade of cell therapy, we now recognize the critical need for the time management of cellular products. Many processes aimed at developing a cell therapy product are vastly ...

Cryopreservation is routinely utilized in a diverse range of areas including cell therapy, tissue engineering, and cell banking. In addition to direct clinical applications, the use of cryopreserved ...

- Partnership with specialist life science distributor establishes sales channel in high-demand market and strengthens global network - Hypothermic preservation technology eliminates costs and ...

In a potential game changer for patients with type 2 diabetes, a team of researchers has identified a therapeutic target for the preservation and regeneration of beta cells -- cells in the pancreas ...

Malignant ovarian germ cell tumors are rare neoplasms that predominantly affect adolescents and young women. These tumours, while highly aggressive if untreated, generally respond well to therapy, ...

Atelerix, a biotech company revolutionizing cell preservation and biological transport with its pioneering hydrogel encapsulation technology, today announced it has signed an exclusive distribution ...